Celera, Applera, University of Oregon, MitoSciences, Proteros, BioSolveIT, Fluidigm, Scripps Translational Science Institute, GeneGo, Power3, ProtAffin Biotechnologie, Intercell | GenomeWeb
Celera Files to Split from Applera
Celera filed with the US Securities and Exchange Commission last week to separate from Applera and become an independent, publicly traded company.
Among the reasons cited by Celera for the split is that it will give the company greater managerial focus and ability to use its stock for acquisitions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.